Publication

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study

Journal Paper/Review - Mar 1, 2005

Ravaud Alain, Cerny Thomas, Terret Catherine, Wanders Jantien, Bui Binh Nguyen, Hess Dagmar, Droz Jean-Pierre, Fumoleau Pierre, Twelves Chris